Aptamer Group reports 27% revenue growth on pharma contracts
Investing.com Gold reports: Aptamer Group reports 27% revenue growth on pharma contracts. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Aptamer Group reports 27% revenue growth on pharma contracts. Full body text was unavailable at ingest time, so this brief is based on headline context.